Michael Singer, MD, PhD

Co-Founder, CSO and Director at Cartesian Therapeutics

Michael Singer is Chief Scientific Officer at Cartesian Therapeutics, a clinical-stage biotech developing RNA cell therapies in and beyond oncology. He has co-founded three life sciences companies. Previously, he led development teams for three different monoclonal antibodies at Novartis. Dr. Singer holds a BS, MD, and PhD from Yale University, where he serves on the external faculty, and completed internship and residency at Harvard Medical School.